MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2018 International Congress

    INTREPID: A Prospective, Double Blinded, Multicenter Randomized Controlled Trial Evaluating Deep Brain Stimulation with a New Multiple Source, Constant Current Rechargeable System in Parkinson’s disease

    J. Vitek, R. Jain, L. Chen, I. Study Group, P. Starr (Minneapolis, MN, USA)

    Objective: INTREPID is designed to assess the improvement in motor function and quality of life in patients with Parkinson’s disease (PD) following Deep Brain Stimulation…
  • 2018 International Congress

    Neuroprotective role of Tinospora cordifolia in MPTP induced Parkinsonian mouse model

    S. Singh, H. Birla, S. Rai, W. Zahra, S. Singh (Varanasi, India)

    Objective: To evaluate the neuroprotective effect of Tinospora cordifolia aqueous extract (TCAE) in Parkinsonian mice. Background: Parkinson’s disease, an age related neurodegenerative disorder, is characterized…
  • 2018 International Congress

    Comparison of virtual-reality-gaming and activity-based gait and balance training on gait, balance and quality of life in patients with Parkinson’s disease

    A. Ogundele, M. Olaogun, M. Komolafe (Ile-Ife, Nigeria)

    Objective: Investigate and compare the effects of virtual-reality-gaming(VRG) and activity-based gait and balance training (AGBT) on gait and balance parameters (cadence(CD), stride length (SDL), step…
  • 2018 International Congress

    Efficacy and safety of Rasagiline in treatment of gait disturbances in dementia with Lewy bodies

    A. Chimagomedova, O. Levin, M. Anikina, I. Ayzenberg (Moscow, Russian Federation)

    Objective: We aimed to investigate the efficacy and safety of rasagiline in addition to levodopa in patients with dementia with Lewy bodies (DLB). Background: Management…
  • 2018 International Congress

    Patients experiencing peak-dose dyskinesia use re-distribution of involuntary movement amplitude throughout their body to minimize the functional impact of dyskinesia

    K. Lebel, E. Goubault, S. Bogard, C. Duval (Montréal, QC, Canada)

    Objective: To investigate the presence of a strategy in dyskinesia amplitude re-distribution enabling patients to perform motor tasks. Background: In Parkinson’s disease (PD), occurrence of…
  • 2018 International Congress

    Global Improvement and Patient Satisfaction: Results from a Long-Term, Open-Label, Rollover Study of Valbenazine in Tardive Dyskinesia

    S. Lessig, S. Marder, C. Verghese, J. Burke, R. Jimenez, S. Siegert, G. Liang (San Diego, CA, USA)

    Objective: To assess global improvement and patient satisfaction in participants with tardive dyskinesia (TD) who received long-term treatment with once-daily valbenazine (VBZ). Background: VBZ, approved…
  • 2018 International Congress

    Incremental hourly burden of “OFF” episodes on patient quality of life and health resource use among patients with Parkinson’s disease: A Neurologist/Patient Real World Assessment in the US

    K. Rajagopalan, J. Barton, J. Pike (Marlborough, MA, USA)

    Objective: To investigate the incremental hourly burden of “OFF” episodes on health resource utilization (HRU) and health- related- quality of life (HRQoL) from a real…
  • 2018 International Congress

    A new distinct spastic ataxia with hypomyelination: Clinical, neuroimaging and molecular expression of NKX6-2 mutations

    V. Chelban, N. Kaya, M. Alsagob, S. Efthymiou, J. Vandrovcova, D. Lynch, K. Kloth, A. Chirita-Emandi, F. Alkuraya, N. Wood, H. Houlden (London, United Kingdom)

    Objective: To identify the phenotypic, neuroimaging and genotype-phenotype expression of NKX6-2 mutations. Background: Despite advances in genetic testing a large number of hyopomyelinating disorders remain…
  • 2018 International Congress

    A Case of Paraneoplastic Myoclonus Attributed to Non-Small Cell Lung Cancer

    J. Nichols (Portland, OR, USA)

    Objective: To describe a patient with papillary Non-Small Cell Lung Cancer (NSCLC) who developed acute and rapidly progressive myoclonus with prominent palatal involvement as a…
  • 2018 International Congress

    Non-motor symptoms and alteration of brain networks in patients with blepharospasm and hemifacial spasm

    YJ. Guo, CM. Chen, MH. Chang (Taichung, Taiwan)

    Objective: To investigate the differences of non-motor symptoms and the alteration of intrinsic brain networks in patients with blepharospasm and hemifacial spam. Background: Blepharospasm (BSP)…
  • 1
  • 2
  • 3
  • …
  • 177
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley